United States
United States

Time filter

Source Type

News Article | April 27, 2017
Site: www.prlog.org

-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today thatwill speak at The Knowledge Group's webcast entitled:This event is scheduled forhttps://theknowledgegroup.org/event-homepage/?event_id=2171Dr. Demperio conducts economic research and analysis in the areas of antitrust, intellectual property economics, commercial damages, public health and policy, and business valuation. In intellectual property, Dr. Demperio has expertise in calculating lost profits and reasonable royalty damages in cases involving patent, copyright, trademark, and trade secret infringement. Her project experience spans a wide variety of industries including agricultural products, apparel, auto parts, chemicals, paper products, telecommunications, food products, and pharmaceuticals. She has supported clients in matters brought before courts and government authorities in the US, Canada, Australia, and the UK.NERA Economic Consulting ( www.nera.com ) is a global firm of experts dedicated to applying economic, finance, and quantitative principles to complex business and legal challenges. For over half a century, NERA's economists have been creating strategies, studies, reports, expert testimony, and policy recommendations for government authorities and the world's leading law firms and corporations. We bring academic rigor, objectivity, and real world industry experience to bear on issues arising from competition, regulation, public policy, strategy, finance, and litigation.NERA's clients value our ability to apply and communicate state-of-the-art approaches clearly and convincingly, our commitment to deliver unbiased findings, and our reputation for quality and independence. Our clients rely on the integrity and skills of our unparalleled team of economists and other experts backed by the resources and reliability of one of the world's largest economic consultancies. With its main office in New York City, NERA serves clients from more than 25 offices across North America, Europe, and Asia Pacific.Section 284 of the US Patent Code mandates that a patentee is entitled to royalty damages for an infringement had there been an infringement suit or none. The minimum grant that the claimant can recover if there had been no suit is the royalty that it and the infringer have agreed upon. Furthermore, in an event where the patentee cannot prove any actual damages, he is still entitled of the said mandate given that the court has assessed the infringing sales. This class is called "reasonable royalty damages."However, some consider the terminology as confusing and misleading. Questions arise as to the "reasonability"of reasonable royalty. In addition, while the Federal Circuit has approved two approaches – the Hypothetical Negotiation and the Analytical Approach – it has stressed that there is no single way to determine reasonable royalty damages.On a lighter note, however, possible approaches which were not explicitly approved by the Federal Circuit such as Rule of Thumb, Established Royalty for the Patent, Many Licenses in a Small Range of Rates, and Cost Savings have already been used in some cases.In this two-hour LIVE Webcast, a panel of key thought leaders organized by The Knowledge Group will provide the audience with an in-depth discussion of the Reasonable Royalty in Patent Damages. Speakers will also help them understand the potential and the approved approaches in determining reasonable royalty damages in patent infringements.Some of the major topics that will be covered in this course are:§  Overview of Reasonable Royalty§  U.S. And Canadian Law Compared and Contrasted§  Hypothetical Negotiation§  Institutional Effects on Calculations§  Extraterritoriality Issues§  Apportionment Analysis§  FRAND ComplianceThe Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/


Gordon K.,NERA | Olson W.P.,NERA | Strunk K.G.,NERA
Electricity Journal | Year: 2011

Because of their investment in long-lived assets with little value in alternative uses, special attention to meeting the terms of the regulatory compact is appropriate. This need not always take the form of full-blown rate cases-there are more targeted tools as well. Targeted and formula-based approaches can play a role in setting just and reasonable rates, based on prudently incurred costs. © 2011 Elsevier Inc.


Makholm J.D.,NERA | Ros A.J.,NERA | Collins S.C.W.,NERA
Electricity Journal | Year: 2012

Three analyses may prove useful to utility-industry stakeholders as performance-based regulation evolves over the coming years. One measures average long-run total factor productivity growth for U.S. electricity distributors. The second surveys PBR plans from the U.S. and Canada for the past two decades. The third suggests ways in which regulators can incorporate "trackers" into PBR plans to deal with particular and ongoing cost items not traditionally covered by PBR plans. © 2012 Elsevier Inc.


The changes in public utility regulation over the past 30 years have been impressive, with market-based approaches and competition now playing a major role in the electric, natural gas, and telecommunications industries. © 2011 Elsevier Inc.


Receive press releases from The Knowledge Group: By Email Dr. David Blackburn with NERA Economic Consulting to Speak at The Knowledge Group’s ANDAs and The Hatch-Waxman Act: Cases, Trends and Developments to Watch For in 2017 New York, NY, February 28, 2017 --( For further details, please visit: https://www.theknowledgegroup.org/andas-and-the-hatch-waxman-act-cases-trends-and-developments-to-watch-for-in-2017-live-webcast/ About Dr. David Blackburn Dr. Blackburn's areas of expertise include intellectual property (IP), antitrust and competition policy, and econometric analysis. He conducts analyses related to the issues of commercial success and preliminary and permanent injunctions in both Inter Partes Review and Abbreviated New Drug Application (ANDA) proceedings pursuant to the Hatch-Waxman Act. Additionally, he conducts research and prepares expert reports for patent, trademark, and copyright infringement disputes, and false and misleading advertising cases. Dr. Blackburn has represented clients in a variety of industries, including medical devices, pharmaceuticals, computer software, natural resources, industrial goods and chemicals, consumer products, entertainment, and financial services. Before joining NERA, Dr. Blackburn received his PhD in economics from Harvard University and his ScB in applied mathematics and economics, with honors, from Brown University. About NERA Economic Consulting NERA Economic Consulting is a global firm of experts dedicated to applying economic, finance, and quantitative principles to complex business and legal challenges. NERA's economists create strategies, studies, reports, expert testimony, and policy recommendations for government authorities and the world’s leading law firms and corporations. NERA’s clients value our ability to apply and communicate rigorous approaches clearly and convincingly, our commitment to deliver unbiased findings, and our reputation for quality and independence. Our clients rely on the integrity and skills of our unparalleled team of economists and other experts backed by the resources and reliability of one of the world’s largest economic consultancies. With its main office in New York City, NERA serves clients from more than 25 offices across North America, Europe, and Asia Pacific. Abstract As the growth rate for Abbreviated New Drug Application (ANDA) filings remain steadier than filing rates for other patent litigation, the pharmaceutical companies and their counsel need to keep themselves abreast of the latest issues hounding the industry. In the face of Hatch-Waxman Act and ANDA applications, the industry should be well-equipped in protecting and maximizing the value of pharmaceutical patents. The Knowledge Group has assembled a panel of key thought leaders and practitioners to provide an opportunity to discuss the various issues surrounding the Hatch-Waxman Act and the Abbreviated New Drug Application (ANDA), which the pharmaceutical industry should watch out for in 2017. The panel of speakers will provide an in-depth discussion of the notable cases, trends, and developments. Speakers will also offer best practices in avoiding and mitigating future litigation risks. Key topics include: - Emerging Trends and Developments - Recent Cases - Potential Litigation Risks and Remedies - Critical Issues and Implications - Best Practices About The Knowledge Group/The Knowledge Congress Live Webcast Series The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/ New York, NY, February 28, 2017 --( PR.com )-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Dr. David Blackburn, Director with NERA Economic Consulting will speak at The Knowledge Group’s webcast entitled: “ANDAs and The Hatch-Waxman Act: Cases, Trends and Developments to Watch For in 2017.” This event is scheduled for April 4, 2017 from 12:00pm to 2:00pm (ET).For further details, please visit: https://www.theknowledgegroup.org/andas-and-the-hatch-waxman-act-cases-trends-and-developments-to-watch-for-in-2017-live-webcast/About Dr. David BlackburnDr. Blackburn's areas of expertise include intellectual property (IP), antitrust and competition policy, and econometric analysis. He conducts analyses related to the issues of commercial success and preliminary and permanent injunctions in both Inter Partes Review and Abbreviated New Drug Application (ANDA) proceedings pursuant to the Hatch-Waxman Act. Additionally, he conducts research and prepares expert reports for patent, trademark, and copyright infringement disputes, and false and misleading advertising cases.Dr. Blackburn has represented clients in a variety of industries, including medical devices, pharmaceuticals, computer software, natural resources, industrial goods and chemicals, consumer products, entertainment, and financial services. Before joining NERA, Dr. Blackburn received his PhD in economics from Harvard University and his ScB in applied mathematics and economics, with honors, from Brown University.About NERA Economic ConsultingNERA Economic Consulting is a global firm of experts dedicated to applying economic, finance, and quantitative principles to complex business and legal challenges. NERA's economists create strategies, studies, reports, expert testimony, and policy recommendations for government authorities and the world’s leading law firms and corporations. NERA’s clients value our ability to apply and communicate rigorous approaches clearly and convincingly, our commitment to deliver unbiased findings, and our reputation for quality and independence. Our clients rely on the integrity and skills of our unparalleled team of economists and other experts backed by the resources and reliability of one of the world’s largest economic consultancies. With its main office in New York City, NERA serves clients from more than 25 offices across North America, Europe, and Asia Pacific.AbstractAs the growth rate for Abbreviated New Drug Application (ANDA) filings remain steadier than filing rates for other patent litigation, the pharmaceutical companies and their counsel need to keep themselves abreast of the latest issues hounding the industry. In the face of Hatch-Waxman Act and ANDA applications, the industry should be well-equipped in protecting and maximizing the value of pharmaceutical patents.The Knowledge Group has assembled a panel of key thought leaders and practitioners to provide an opportunity to discuss the various issues surrounding the Hatch-Waxman Act and the Abbreviated New Drug Application (ANDA), which the pharmaceutical industry should watch out for in 2017. The panel of speakers will provide an in-depth discussion of the notable cases, trends, and developments. Speakers will also offer best practices in avoiding and mitigating future litigation risks.Key topics include:- Emerging Trends and Developments- Recent Cases- Potential Litigation Risks and Remedies- Critical Issues and Implications- Best PracticesAbout The Knowledge Group/The Knowledge Congress Live Webcast SeriesThe Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/ Click here to view the company profile of The Knowledge Group Click here to view the list of recent Press Releases from The Knowledge Group


News Article | December 6, 2016
Site: news.yahoo.com

“Making America Rich Again: The Latino Effect on Economic Growth.” No, it’s not a parody of President-elect Donald Trump’s campaign slogan. It’s the title of a new report written by Jeffrey Eisenach, SVP at NERA Economic Consulting and a member of Trump’s transition team. Commissioned by the nonpartisan Latino Donor Collaborative (LDC) and the Royal Bank of Canada (RBC) and authored by Eisenach and his staff at NERA, the report is particularly timely. The US has been swept up in heated politicization of Latinos, fueled by Trump’s promise to build a wall between Mexico and the US and his declaration that “we have some bad hombres here, and we’re going to get them out.” LDC co-founder Sol Trujillo told Yahoo Finance that he had one primary objective for the report: to debunk Latino stereotypes. He says they were able to find empirical evidence that Latinos are playing a critical role in rejuvenating the American workforce. Between 1990 and 2015, the Latino population in the US grew from 22 million to 57 million, about five times as fast as the overall population. The median age for Latinos in the US is 28 years old (compared to 37 for the population at large and 43 for the white population). As an economist, Eisenach says he occasionally sees a piece of data that may be interesting or exciting but doesn’t fit with a larger phenomenon and doesn’t tell a full story. This data on Latinos, however, sheds light on the potential of people behind a big demographic shift in the US. In the case of Latinos, be they entrepreneurs, consumers, marketers or wealth managers, there is a rich road of opportunity ahead. He says the data speaks for itself. “The data surrounding Latinos’ economic implications pull together a story that’s compelling, pervasive and deep. Especially because the average Latino is nine years younger than the overall population, we know that this demographic will be with us for a while, and we can take advantage of that,” he says. In addition to holding a Ph.D. in economics, Eisenach has been an outspoken advocate for less regulation, and has been a consultant who worked for Verizon (VZ) and other companies in the telecommunications space to push back against the Federal Communications Commission (FCC). He’s co-leading Trump’s telecommunications policy team, which means he’s responsible for hiring the new staff members of the FCC. He says he decided to pursue this report through the lens of economics, not politics.  “The study is completely separate from my relationship with Trump,” he says. “I embarked on this as an economist.” Eisenach says he was surprised by much of the data. For example, Latinos are creating new businesses and increasing headcount at a faster pace than the overall population. Hispanics have had the highest entrepreneurship rate of any ethnic group each year since 2002. Latinos accounted for more than one out of five new entrepreneurs, up from 10% in 1996. Of course, many of these businesses remain small — there are over 4 million Latino-owned business in the US, but only 2% of them earn over $1 million in annual revenue, according to data compiled by the Hispanic Chamber of Commerce. And, despite the threat of wage stagnation over the past several years, Eisenach says Latinos are responsible for 29% of real income growth in the US between 2005 and 2015, with the number of Latino households with incomes over $150,000 growing 194% over the same period. Though the median income among Latino households is below the country’s average, the growth is rapid, and signals significant momentum for the Latino population. In fact, over the last decade (between 2005 to 2015), Hispanics — who account for just 18% of the population — accounted for 29% of the growth in real aggregate income. Bureau of Labor Statistics data show that median weekly earnings of full-time wage and salary workers rose nearly 11% for Hispanics between the first quarter of 2000 and the first quarter 2016, more than triple the increase for the population overall. And according to the November employment report, the trend remains positive for the Latino jobs picture. The unemployment rate among Latinos held steady at 5.7% (compared to 4.6% for the entire country). Trujillo hopes that business leaders and government officials can marry knowledge from this report with capital investments to recognize the “organic growth that is happening.” He says the Latino population is a bright spot in what he calls the “new mainstream economy” that supports a highly educated, tech savvy population, specifically citing 3D printing and robotics as examples of the innovative industries that are burgeoning in the US. Both Trujillo and Eisenach say they are extremely optimistic about the country. Though Eisenach says he wishes not to speak about Trump directly as a member of his transition team, he disclosed that he was not supporting Trump as a candidate in the beginning and that he began working on the report in January, when he was actually supporting Marco Rubio during the primaries. Meanwhile, Trujillo says regardless on one’s immigration views, it’s vital to leverage the talent that already exists in the US. “We need to fix the conversation about how Latinos are vital to the economy. Deportations should not be the core message.” “We should always be thinking about catalyzing and facilitating those areas of growth as opposed to putting up barriers and hindrances,” he adds. “I’m not here to criticize. I’m hopeful that our new administration will use the data to implement a smart strategy. Our job is to grow, to look to the future, and not to recreate growth strategies from 20-30 years ago.” Latino business leaders like Trujillo hope that Trump can harness the data to recognize that the subsector of the population is young, growing fast and accumulating wealth. Because, perhaps, the very people he has alienated can help make the country great — and rich — again. Melody Hahm is a writer at Yahoo Finance, covering entrepreneurship, technology, real estate and immigration. Follow her on Twitter @melodyhahm.

Loading NERA collaborators
Loading NERA collaborators